Cargando…
Inhibition of the anti-apoptotic protein MCL-1 severely suppresses human hematopoiesis
BH3-mimetics inhibiting anti-apoptotic BCL-2 proteins represent a novel and promising class of antitumor drugs. While the BCL-2 inhibitor venetoclax is already approved by the Food and Drug Administration, BCL-XL and MCL-1 inhibitors are currently in early clinical trials. To predict side effects of...
Autores principales: | Bohler, Sheila, Afreen, Sehar, Fernandez-Orth, Juncal, Demmerath, Eva-Maria, Molnar, Christian, Wu, Ying, Weiss, Julia Miriam, Mittapalli, Venugopal Rao, Konstantinidis, Lukas, Schmal, Hagen, Kunze, Mirjam, Erlacher, Miriam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634190/ https://www.ncbi.nlm.nih.gov/pubmed/33241675 http://dx.doi.org/10.3324/haematol.2020.252130 |
Ejemplares similares
-
In vitro and in vivo evaluation of possible pro-survival activities of PGE2, EGF, TPO and FLT3L on human hematopoiesis
por: Demmerath, Eva-Maria, et al.
Publicado: (2019) -
BCL-XL expression is essential for human erythropoiesis and engraftment of hematopoietic stem cells
por: Afreen, Sehar, et al.
Publicado: (2020) -
The role of inflammation in hematopoiesis and bone marrow failure: What can we learn from mouse models?
por: Wang, Jun, et al.
Publicado: (2022) -
Checkpoint kinase 1 is essential for fetal and adult hematopoiesis
por: Schuler, Fabian, et al.
Publicado: (2019) -
Neonatal Platelets: Lower G(12/13) Expression Contributes to Reduced Secretion of Dense Granules
por: Schlagenhauf, Axel, et al.
Publicado: (2022)